UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059392
Receipt number R000067235
Scientific Title Supporting Treatment Adherence and Resilience in Kids
Date of disclosure of the study information 2025/10/14
Last modified on 2025/10/14 15:47:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Supporting Treatment Adherence and Resilience in Kids

Acronym

STAR KIDS

Scientific Title

Supporting Treatment Adherence and Resilience in Kids

Scientific Title:Acronym

STAR KIDS

Region

Asia(except Japan)


Condition

Condition

Asthma, Eczema, Cardiac conditions

Classification by specialty

Cardiology Pneumology Pediatrics
Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The goal of the STAR KIDS (Supporting Treatment Adherence and Resilience in Kids) research is to promote better adherence to treatment plan and advice among paediatric patients (particularly children with asthma, eczema, and cardiac condition) and their families. The needs assessment aims to provide initial insight on experiences, barriers, facilitators, and suggested improvements or new initiatives related to treatment adherence by means of interviewing children, parents, as well as Healthcare Professionals (HCPs). The results of the needs assessment will be used to create interventions/education materials/support programmes/tools with the goal to improve the quality of life and health-related outcomes of children.

Basic objectives2

Others

Basic objectives -Others

Improvements in patient adherence to treatment plan (inhaler use, topical therapy, oral medication), and their associated advice (exercise, dust/allergen control, environmental control, diet modification, etc.)

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase III


Assessment

Primary outcomes

As this is a supporting treatment adherence study, the primary outcomes are how well the participants follow the treatment plan and associated advice as directed by their doctors (and other healthcare professionals). For appropriate asthma inhaler use, this would be achieved via Medication Possession Ratio, Proportion of Days Covered, Medication Implementation/Adherence Questionnaires, medical record review, etc. For other advice this would be achieved depending on the nature of the advice, for example removal of pets by asking family members/home visit/proxy interviews, shortening of bath time by digital timer, laundry care and allergen control by home visit and purchase proof, food photograph and random checks, etc.

Key secondary outcomes

Heath-related Quality of Life, Step-up therapy (e.g. via GINA steps review from medical records), Hospitalization and emergency department visit, Qualitative interviews on treatment adherence, Patients' and Providers' evaluation of the intervention/support/tools/education materials, Surveillance, cost analysis, and HTA.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

The intervention is additional resources/supports/tools to facilitate adherence to treatment plan based on the results of a formal needs assessment. This may include home visit, directly observed therapy to improve inhaler technique, teleconsultations, help-line via chat, educational material, medication delivery, dietitian support, subsidy/cost adjustments, etc.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

2 years-old <=

Age-upper limit

20 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Must have an established diagnosis of asthma, atopic dermatitis or eczema, or a cardiac condition requiring long-term Warfarin therapy (e.g., atrial fibrillation, cardiac valve-related condition/replacement, post-Fontan operation).
2. Must be receiving the treatment of interest (inhaled corticosteroids for asthma, any topical treatment for atopic dermatitis or eczema, or Warfarin therapy for a cardiac condition), in KKH.
3. Must be aged 10 to 20 years
4. Singapore Citizen or Singapore Permanent Resident
5. Able to communicate in English
6. The participant must provide consent to be interviewed at least three times: the first interview will be conducted face-to-face, and the subsequent interviews will be at three months and six months, which may be face-to-face or via phone calls, depending on the participant's preference.
7. The participant must provide consent for the interviews to be audio-recorded.

Key exclusion criteria

1. The participant has a plan to move overseas within the next six months.
2. The participant has an unfavorable prognosis with a life expectancy of less than 24 months.
3. The participant is involved in other research or clinical trials that could interfere with the study's data collection or analysis.
4. The participant has significant cognitive or communication impairments that would hinder effective participation in interviews or the informed consent process.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Jean Yin
Middle name
Last name Oh

Organization

KK Women's and Children's Hospital, SingHealth Duke-NUS, Singapore

Division name

Department of Paediatrics

Zip code

229899

Address

100 Bukit Timah Road

TEL

+6562255554

Email

starkids+research@kkh.com.sg


Public contact

Name of contact person

1st name KKH
Middle name
Last name General Enquiry

Organization

KK Women's and Children's Hospital, SingHealth Duke-NUS, Singapore

Division name

Department of Paediatrics

Zip code

229899

Address

100 Bukit Timah Road

TEL

+6562255554

Homepage URL

https://www.kkh.com.sg/

Email

research@kkh.com.sg.


Sponsor or person

Institute

KK Women's and Children's Hospital, SingHealth Duke-NUS, Singapore

Institute

Department

Personal name



Funding Source

Organization

Low Tuck Kwong Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Singapore


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

SingHealth Centralised Institutional Review Board

Address

10 Hospital Boulevard, #19-01 SingHealth Tower, Singapore 168582

Tel

+6581263660

Email

irb@singhealth.com.sg


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

KK Women's and Children's Hospital (Singapore), SingHealth Duke-NUS Academic Medical Centre (Singapore)


Other administrative information

Date of disclosure of the study information

2025 Year 10 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 08 Month 08 Day

Date of IRB

2025 Year 08 Month 08 Day

Anticipated trial start date

2025 Year 08 Month 24 Day

Last follow-up date

2028 Year 08 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 10 Month 14 Day

Last modified on

2025 Year 10 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067235